Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADHD in children: medication versus mindfulness
NL-OMON22179Not yet recruiting
- Sponsor
- University of Amsterdam
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by University of Amsterdam. Primary endpoints: Attention, hyperactivity, and impulsivity symptoms and Free of DSM classification. Planned start Jan 2014; status: not yet recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON22179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22179.